Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Short-Term Debt repayments (2016 - 2025)

Avanos Medical's Short-Term Debt repayments history spans 7 years, with the latest figure at $25.0 million for Q1 2025.

  • On a quarterly basis, Short-Term Debt repayments rose 150.0% to $25.0 million in Q1 2025 year-over-year; TTM through Dec 2025 was $25.0 million, a 44.44% decrease, with the full-year FY2025 number at $25.0 million, down 44.44% from a year prior.
  • Short-Term Debt repayments hit $25.0 million in Q1 2025 for Avanos Medical, roughly flat from $25.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt repayments for AVNS hit a ceiling of $130.0 million in Q2 2022 and a floor of -$55.0 million in Q4 2021.
  • Historically, Short-Term Debt repayments has averaged $27.3 million across 5 years, with a median of $20.0 million in 2022.
  • Biggest five-year swings in Short-Term Debt repayments: crashed 1200.0% in 2021 and later surged 1200.0% in 2022.
  • Tracing AVNS's Short-Term Debt repayments over 5 years: stood at -$55.0 million in 2021, then skyrocketed by 136.36% to $20.0 million in 2022, then skyrocketed by 375.0% to $95.0 million in 2023, then plummeted by 73.68% to $25.0 million in 2024, then changed by 0.0% to $25.0 million in 2025.
  • Business Quant data shows Short-Term Debt repayments for AVNS at $25.0 million in Q1 2025, $25.0 million in Q4 2024, and $10.0 million in Q3 2024.